Beyfortus (Nirsevimab)
- Medicine Name: Beyfortus
- Generic Name: Nirsevimab
- Dosage Form & Strength: Injection: 50 mg/0.5 mL & 100 mg/mL in a single-dose pre-filled syringe
- Manufactured By: AstraZeneca
Beyfortus is a respiratory syncytial virus (RSV) F protein-directed fusion inhibitor used for the prevention of serious lung disease caused by Respiratory Syncytial Virus (RSV) in:
- Newborns and babies aged under 12 months born during or entering their first RSV season.
- Children up to age of 24 months who remain at risk of serious RSV disease through their second RSV season.
Recommended Dosage:
Newborns and babies: First RSV Season: The recommended dosage for newborns and babies during or entering their first RSV season is based on body weight and is administered as a single intramuscular (IM) injection.
- The recommended dosage is 50 mg if less than 5 kg in body weight.
- The recommended dosage is 100 mg if greater than or equal to 5 kg in body weight.
Children Who Remain at Increased Risk for Serious RSV Disease: The recommended dosage is a single 200 mg dose administered as two intramuscular (IM) injections (2 x 100 mg).
Children Undergoing Cardiac Surgery with Cardiopulmonary Bypass: For children undergoing cardiac surgery with cardiopulmonary bypass, an additional Beyfortus dose is recommended as promptly as the child is stable after surgery to ensure adequate nirsevimab serum levels. The recommended dosage is administered as an intramuscular (IM) injection.
First RSV season: In case surgery is within 90 days after taking Beyfortus therapy, the additional dose of Beyfortus should be based on body weight at the time of the additional dose. If more than 90 days have passed since receiving treatment, the additional dose should be 50 mg irrespective of body weight.
Second RSV season: In case surgery is within 90 days after taking Beyfortus therapy, the additional dose should be 200 mg, irrespective of body weight. If more than 90 days have passed since receiving treatment, the additional dose should be 100 mg, irrespective of body weight.
- Severe hypersensitivity reactions, including anaphylaxis, may occur with other IgG1 (human immunoglobulin G1) monoclonal antibodies. In case of signs and symptoms of a clinically significant hypersensitivity reaction or anaphylaxis, initiate apt medicines and/or supportive treatment.
- As with any other intramuscular (IM) injections, Beyfortus 50 mg/0.5 mL & 100 mg/mL should be administered with extra caution to infants and children with thrombocytopenia, any coagulation complications, or to individuals on anticoagulation therapy.
- The medicine Nirsevimab injection must not be mixed with any vaccine in the common syringe or vial. When used concomitantly with any injectable vaccines, they must be given with separate syringes and at new injection sites.
- As with any other intramuscular (IM) injections, nirsevimab injection must be administered with extra caution to infants with thrombocytopenia or any coagulation disorder.
What documents are required to import BEYFORTUS to India?
BEYFORTUS (nirsevimab-alip) injections can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients ID proof (issued by the government of India)
How does the order be confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from Doctor
- Import permit if applicable
BEYFORTUS (nirsevimab injections) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability of Beyfortus in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
IPN (Indian Pharma Network) can facilitate the supply of BEYFORTUS (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Beyfortus price in India.
We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
What is the Generic Name for the trade name drug Beyfortus®?
Nirsevimab is a Generic Name for the trade name drug Beyfortus®.
What is the Manufacturer’s Name of Beyfortus®?
Beyfortus® is manufactured by AstraZeneca.
Is Beyfortus® approved by the FDA?
Yes, Beyfortus® is approved by the FDA. Date of first approval: July 17, 2023.
Where can I get Beyfortus® at the best price in India?
To get the best Beyfortus price in India, kindly connect with the Indian Pharma Network (a WHO GDP & ISO 9001:2008 certified company). For Beyfortus®, a medical prescription is required from your treating physician.
What is the dosage and form of Beyfortus® supplied?
Beyfortus is supplied as Injection: 50 mg/0.5 mL and 100 mg/mL in a single-dose pre-filled syringe 50 mg for intramuscular use.
What are the most common side effects of Beyfortus®?
The most common side effects of Beyfortus® are injection site reactions and rash.
How much does Beyfortus® cost in India?
The Beyfortus cost in India can vary. In order to procure this medication legally, you can call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.
What are the storage conditions of Beyfortus®?
Store refrigerated between 36-46°F (2°C to 8°C). It may be kept at room temperature 68-77°F (20-25°C) for a maximum of 8 hours. After removal from the refrigerator, it must be used within 8 hours. Store it in the original carton to protect it from light until the time of use. Neither freeze nor shake it. Do not be exposed to heat.
Is it safe to buy Beyfortus® online in India?
Yes, one can buy Beyfortus online in India at the lowest price from the Indian Pharma Network (IPN) if the medication Beyfortus® is not (yet) registered or is unavailable in your country. We can facilitate the supply of Beyfortus® through legal channels.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.